Login
Toggle navigation
Videos
Categories
Trending
Mike Crawley, CEO of Northland Power Inc., shares insights in "The View From The C-Suite" segment.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Mike Crawley. President/CEO, Northland Power Inc ;
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:00:00
Lloyd Diamond, CEO, Pixium Vision S
00:10:00
True Precious Metals: Strategic Position and Strong Financing in Central Newfoundland Gold Belt
00:10:00
investor Matt Huang to back disruptive crypto|Fred Ehrsam,Co-Founder,Paradigm
00:00:00
Jeffrey F. Eisenberg Chief Executive Officer, Xenetic Biosciences Inc
00:10:00
"PagerDuty CEO Jennifer Tejada discusses the company's quarterly earnings results and addresses related commentary on 'TechCheck'."|Jennifer Tejada is the Chairperson and CEO of PagerDuty
00:10:00
Protecting Assets from Catastrophic Illness and Medicaid Spend Down | Dave Gner, Founder, Legacy Financial Strategies, Inc.
00:10:00
Interview with Dmitry Suschov of Eurasia Mining at 121 Mining Investment London 2019 Spring
00:10:00
The pandemic accelerated our focus on operational resilience and digital transformation.
00:10:00
Cleary Gottlieb Receives 2016 Pro Bono Publico Award | Michael L. Ryan - Senior Counsel of Cleary Gottlieb Steen & Hamilton LLP
00:10:00
Barrick Gold: Leading in Gold and Copper Production
00:10:00
Mineral Commodities: Expanding Operations in Mineral Sands and Graphite, Focused on Value Creation
00:10:00
ACEN CEO Eric Francia provides insights on the renewable energy market in the Philippines.